Home › Hepatoblastoma › Massachusetts
Hepatoblastoma clinical trials in Massachusetts
3 studies for Hepatoblastoma are looking for participants at sites in Massachusetts.
Cities in Massachusetts
A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment
- Dana Farber Cancer Institute (Data Collection Only), Boston
RecruitingPhase 1
Ages 1 to 21 · All sexes · Updated Sep 1, 2026 · NCT04928677Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Dana-Farber Cancer Institute, Boston
RecruitingPhase 1/2
12 Months – 30 Years · All sexes · Updated Aug 25, 2026 · NCT04851119ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma
- Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston
RecruitingPhase 1/2
Ages 1 to 21 · All sexes · Updated Jul 6, 2026 · NCT04634357From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.